BIO International Convention
We return to BIO 2023 in Boston with a full lineup of educational and networking opportunities around AI + Healthcare.
Tuesday, June 6
Bio from the Bayou Cocktail Reception
Co-Hosted by New Orleans BIO
7:00 p.m. - 9:00 p.m.
Open to active AAIH Members in good standing.
Thursday, June 8
PDUFA VII and Beyond: Building Confidence in AI Tools as New “Gold Standards” for Drug Development
Companies and regulators are turning to artificial intelligence and machine learning models across the entire life-cycle of product development, from drug discovery and clinical research to postmarket safety surveillance, to help make drug development more efficient and optimize real-world patient outcomes. In early May 2023, FDA issued a discussion paper on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biologic Product,s requesting stakeholder feedback on how to best develop “standards for trustworthy AI that address specific performance in areas such as explainability, reliability, privacy, safety, security, and bias mitigation
9:00 a.m. -10:00 a.m. in Session Room 254B
Panelists include:
Paul Howard, Senior Director of Public Policy, Amicus Therapeutics (moderator)
Maria Luisa Pineda, CEO, Envisagenics
Stacy Amin, Partner, Morrison Foerster
Joseph Lehar, SVP, R&D Strategy, Owkin